Finasteride-loaded nano-lipidic carriers for follicular drug delivery: preformulation screening and Box-Behnken experimental design for optimization of variables

Finasteride (FIN), a 5-α reductase enzyme inhibitor is mainly used orally for the treatment of androgenic alopecia and benign prostate hyperplasia. The present study was undertaken for systematic optimization and assessment of the designed nanostructured lipid carriers (NLC) to enhance follicular de...

Descripción completa

Detalles Bibliográficos
Autores principales: Ramkar, Shweta, Suresh, Preeti K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9420366/
https://www.ncbi.nlm.nih.gov/pubmed/36042733
http://dx.doi.org/10.1016/j.heliyon.2022.e10175

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9420366/
https://www.ncbi.nlm.nih.gov/pubmed/36042733
http://dx.doi.org/10.1016/j.heliyon.2022.e10175

Ejemplares similares